Sofinnova Investments Fund I

Sofinnova Investments

Status

ACTIVE

Global HQ

New York, United States

Countries of investment

Investment stages

Pre-Seed
Seed

Industries

About
Sofinnova Investments is a leading clinical-stage biopharmaceutical venture capital firm dedicated to transforming innovative ideas into viable therapeutics. With approximately $3.0 billion in assets under management and a strong commitment to advancing life sciences, Sofinnova leverages its extensive experience and deep industry insights to identify and support groundbreaking companies. By deploying both human and financial capital, Sofinnova plays a pivotal role in fostering the development of promising drug candidates that address unmet medical needs. The firm's strategic investments and collaborative approach enable it to drive significant advancements in healthcare and contribute to the evolution of the biopharmaceutical landscape.

Min check size: $1M
Max check size: $20M
Fund size: Unlock
NPS: Unlock

Investment Thesis

Invests in biotechnology and life sciences startups with a focus on advanced technologies and innovations.

Lead investor: Unlock
Co Invest: Unlock
Number of exits: Unlock
Preferred contact method: Unlock

Manager's Experience

Leveraging extensive experience in the life sciences and technology sectors, the fund manager has successfully completed over 35 investments across North America and Europe. With a strategic emphasis on operator-first approaches, they have facilitated notable exits that underscore their commitment to driving value. Their focus on early-stage ventures allows for the cultivation of innovative companies poised for growth. This data-driven style enhances decision-making and reinforces a robust portfolio that aligns with emerging market trends.